(CME145) Wound Molecular Testing: Understanding the Latest Evidence and Navigating Pitfalls

Friday, March 27, 2026

4:15 PM - 5:15 PM PT

Room: Platinum Ballroom 1-2

CE: 1

CME: (1.0) MOC: (1.0) CMD Clinical: (1.0) AAFP (1.0)

Lead Speaker(s)

Jessica Zering, PharmD, BCIDP, BCPS, CAPM

Antimicrobial Stewardship Pharmacist
Washington State Department of Health
Richland, Washington

Slides PDF

Speaker(s)

Muhammed Salman Ashraf, MBBS, FIDSA

Associate Professor
University of Nebraska Medical Center
Omaha, Nebraska
Chikal Patel, MD

Medical Director
Optum/UnitedHealth Group
Mesa, Arizona
Swati O. Gaur, MD, MBA, CMD, AGSF

Chief Medical Officer
Senior Care Office
Alpharetta, Georgia

Session Summary: This interdisciplinary panel discussion will discuss the currently available literature and data on wound molecular testing in the context of a patient case. The audience will learn about the current literature and evidence gaps surrounding the role of this testing in both diagnosis and antibiotic stewardship. Data related to the current landscape of wound molecular test ordering practices in the United States will also be reviewed, as will appropriate evaluation of wound infections and collaboration between the medical director and specialist. Audience members will be given the opportunity to ask questions of this expert panel and interactive discussion will be utilized to engage throughout the presentation.

Learning Objectives:

At the completion of this session, learners will be able to:

Discuss the role of the medical director in wound care
Discuss the proper evaluation of wound infections
Summarize the literature currently available regarding wound molecular tests